Free Trial

Xylem Inc. $XYL Shares Sold by Canada Pension Plan Investment Board

Xylem logo with Business Services background

Key Points

  • The Canada Pension Plan Investment Board has reduced its stake in Xylem Inc. by 4.7%, selling 8,297 shares, and now owns 168,334 shares worth approximately $20 million.
  • Several other institutional investors have also adjusted their positions in Xylem, with increases in stakes ranging from 3% to 84.9% among different firms during the first quarter.
  • Xylem recently announced a quarterly dividend of $0.40 per share, reflecting an annual yield of 1.1% and a payout ratio of 41.56%.
  • Five stocks we like better than Xylem.

Canada Pension Plan Investment Board decreased its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 4.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 168,334 shares of the industrial products company's stock after selling 8,297 shares during the quarter. Canada Pension Plan Investment Board owned about 0.07% of Xylem worth $20,109,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Center for Financial Planning Inc. increased its stake in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 91 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Xylem by 3.0% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,450 shares of the industrial products company's stock valued at $412,000 after purchasing an additional 99 shares during the period. Valley National Advisers Inc. increased its position in Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after purchasing an additional 101 shares during the last quarter. Ascent Wealth Partners LLC raised its stake in Xylem by 0.7% during the first quarter. Ascent Wealth Partners LLC now owns 14,229 shares of the industrial products company's stock worth $1,700,000 after purchasing an additional 101 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of Xylem by 25.1% in the 1st quarter. Blue Trust Inc. now owns 539 shares of the industrial products company's stock valued at $64,000 after purchasing an additional 108 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

XYL has been the topic of several research reports. TD Cowen increased their target price on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research report on Tuesday, August 26th. Stifel Nicolaus raised their price objective on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Raymond James Financial raised Xylem to a "hold" rating in a research note on Thursday, May 15th. Cowen reissued a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Six equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $152.29.

Get Our Latest Analysis on Xylem

Xylem Trading Down 1.7%

NYSE XYL opened at $141.57 on Tuesday. The company has a market capitalization of $34.46 billion, a price-to-earnings ratio of 36.77, a price-to-earnings-growth ratio of 2.45 and a beta of 1.09. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $145.33. The company's fifty day moving average price is $136.37 and its two-hundred day moving average price is $126.90.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same period in the previous year, the company earned $1.09 earnings per share. Xylem's quarterly revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's dividend payout ratio (DPR) is 41.56%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines